110 related articles for article (PubMed ID: 19362658)
1. Wound healing: from embryos to adults and back again.
Tredget EE; Ding J
Lancet; 2009 Apr; 373(9671):1226-8. PubMed ID: 19362658
[No Abstract] [Full Text] [Related]
2. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.
Occleston NL; Fairlamb D; Hutchison J; O'Kane S; Ferguson MW
Expert Opin Investig Drugs; 2009 Aug; 18(8):1231-9. PubMed ID: 19604123
[TBL] [Abstract][Full Text] [Related]
3. Prevention of buccal mucosa scarring with transforming growth factor β3.
Ohno S; Hirano S; Kanemaru S; Tateya I; Kitani Y; Kojima T; Nakamura T; Ito J
Laryngoscope; 2011 Jul; 121(7):1404-9. PubMed ID: 21647892
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β3 for the prevention of vocal fold scarring.
Ohno S; Hirano S; Kanemaru S; Kitani Y; Kojima T; Ishikawa S; Mizuta M; Tateya I; Nakamura T; Ito J
Laryngoscope; 2012 Mar; 122(3):583-9. PubMed ID: 22252900
[TBL] [Abstract][Full Text] [Related]
6. Avotermin: a novel antiscarring agent.
Durani P; Occleston N; O'Kane S; Ferguson MW
Int J Low Extrem Wounds; 2008 Sep; 7(3):160-8. PubMed ID: 18757391
[TBL] [Abstract][Full Text] [Related]
7. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
Occleston NL; O'Kane S; Laverty HG; Cooper M; Fairlamb D; Mason T; Bush JA; Ferguson MW
Wound Repair Regen; 2011 Sep; 19 Suppl 1():s38-48. PubMed ID: 21793965
[TBL] [Abstract][Full Text] [Related]
8. Effects of avotermin (transforming growth factor β3) in a clinically relevant pig model of long, full-thickness incisional wounds.
Laverty HG; Occleston NL; Johnson M; Little J; Jones R; Fairlamb D; Ferguson MW; O'Kane S
J Cutan Med Surg; 2010; 14(5):223-32. PubMed ID: 20868619
[TBL] [Abstract][Full Text] [Related]
9. High blood pressure (hypertension) may influence the results of clinical trials for scar and keloid treatments.
Ogawa R
Plast Reconstr Surg; 2013 Dec; 132(6):1074e-1075e. PubMed ID: 24281621
[No Abstract] [Full Text] [Related]
10. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
Ferguson MW; O'Kane S
Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
[TBL] [Abstract][Full Text] [Related]
11. Scar treatments: preclinical and clinical studies.
Reish RG; Eriksson E
J Am Coll Surg; 2008 Apr; 206(4):719-30. PubMed ID: 18387479
[No Abstract] [Full Text] [Related]
12. Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.
Occleston NL; Laverty HG; O'Kane S; Ferguson MW
J Biomater Sci Polym Ed; 2008; 19(8):1047-63. PubMed ID: 18644230
[TBL] [Abstract][Full Text] [Related]
13. [Effects of the zinc oxide and cod liver oil containing ointment Zincojecol in an animal model of wound healing].
Kietzmann M; Braun M
Dtsch Tierarztl Wochenschr; 2006 Sep; 113(9):331-4. PubMed ID: 17009808
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II clinical trial of avotermin versus placebo for scar improvement.
McCollum PT; Bush JA; James G; Mason T; O'Kane S; McCollum C; Krievins D; Shiralkar S; Ferguson MW
Br J Surg; 2011 Jul; 98(7):925-34. PubMed ID: 21618480
[TBL] [Abstract][Full Text] [Related]
15. Scar wars.
Ferguson MW
Br Dent J; 2002 Apr; 192(8):475. PubMed ID: 12014697
[No Abstract] [Full Text] [Related]
16. [What's new in dermatological therapy?].
Dupuy A
Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S263-72. PubMed ID: 22202648
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta3 affects plasminogen activator inhibitor-1 expression in fetal mice and modulates fibroblast-mediated collagen gel contraction.
Li WY; Huang EY; Dudas M; Kaartinen V; Warburton D; Tuan TL
Wound Repair Regen; 2006; 14(5):516-25. PubMed ID: 17014662
[TBL] [Abstract][Full Text] [Related]
18. TGF-ß in wound healing: a review.
Douglas HE
J Wound Care; 2010 Sep; 19(9):403-6. PubMed ID: 20852569
[TBL] [Abstract][Full Text] [Related]
19. Scar revision review.
Thomas JR; Somenek M
Arch Facial Plast Surg; 2012; 14(3):162-74. PubMed ID: 22801760
[TBL] [Abstract][Full Text] [Related]
20. To hit a moving target.
Shanahan D
J Wound Care; 2012 Sep; 21(9):419. PubMed ID: 22990393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
